| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Franchising > Franchising Industry Burdened in Over Regulation |
|
Advice You - Franchising Industry Burdened in Over Regulation
There were only an estimated 1800 active franchisors in this country at the end of 2002, that number down from 6000 in a single decade. It is not hard from this ef According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product fort to increase regulations to see why. I believe the Federal Trade Commission’s franchising expenditures should be cut by the same rate of decline after all they ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in caused it. Why is the Federal Trade Commission favoring one business model over another, actually the franchising model lowers prices to consumers through economie lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. s of scale, efficiency of operations and competition. Any and all increased regulation over the franchising business model is a clear sign that the Federal Trade C here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe mmission is titling the field for the larger corporate box store and by doing so is hurting our country, decreasing competition in the market place and decreases ch d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ices for forward advancement of every citizen who wants to have a fulfilled life and a meaningful job. Shame on you, FTC; what an insidious consequence of this ru ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc le-making group at the Federal Trade Commission? Such a small group gets to decide the fate of hundreds of thousands of American workers and the destiny’s of thous easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi nds of America’s future bright star entrepreneurs and innovators. If this whole process is not evil, then I cannot even imagine what is? Franchising accounts for nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ne third of every consumer dollar spent in the US. How can the Federal Trade Commission go against the clear choice of the consumer who votes with their dollars ev and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ery single day, day in and day out for franchising. Franchising has standards of operation and consumers know what they are getting, and collectively they have wor ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ed harder and achieved more than their independent counterparts towards this goal. The consumers have voted for franchising and now the Federal Trade Commission wa ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ts to recount CHADS and require franchisors to give information to any one who asks even if that person in misrepresenting themselves. Yet at the same time we have dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod “know your customer laws” and on the other hand privacy rights and things you cannot ask, yet all the while requiring more disclosure of information which is priva cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e? Can anyone see that this patchwork of bad legislation, over disclosure, case law and regulations is sinking the best of what America has to offer? Step back an tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen look at this mess? It is not reality based it is some ingenious scheme to steal from American Innovation and Free Markets in some contrived or perceived reality w t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel hich represents nothing. Franchising exists in Western Culture and was created here, because it is a win-win. If the franchisee wins the franchisor wins and vice- ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ersa, now we have created nice little boxes with definitions where no one wins except the lawyers, who have never created or built anything. Through trickery the r y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products gulatory bodies somehow believe they are doing the right thing, because a lawyer told them so? Wow, since when has a lawyer ever known any reality except words on . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de paper and manipulation of reality into some mangled word-smithing of self serving propaganda? Please state the exact year, date, court and citation number of when elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ou believe an honest attorney uttered a word of truth? Think about this as these comments are completely visible to those who live in reality, thanks for listening tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Increase Your Chance of Promotion at Work Business Development: The Basic Ingredients
|